SELLAS Life Sciences Group, Inc. (SLS) Q2 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Celeste, Life Sciences Investor Symposium on GPS. At this time, all participants are in a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I would now like to turn the conference over to Allison Sauce, Investor Relations. Thank you. You may begin. Thank you. Good afternoon, everyone. I am Allison Sauce from KCSA Strategic Communications. and it is my pleasure to welcome you to the Pellis Investor Symposium on Gallup Express for GPS. For those of you who have dialed in rather than joining by webcast, I would like to remind you that there are presentation slides accompanying this call. To view the slides, please join the webcast, which is available on the Investor Relations section of Pellis' website, as well as in the event press release. Next, I would like to remind you that Pellis will be making forward-looking statements Such forward-looking statements can be identified by the use of the words expect, believe, will, anticipate, estimate, plan, project, and other words of similar import. The forward-looking statements in the presentation include, they're not limited to statements related to the potential commercial opportunity for our clinical candidate, GPS. These forward-looking statements are based on current plans, objectives, estimates, expectations, and intentions, and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include without limitation risks and uncertainties associated with the COVID-19 pandemic and its impact on the company's clinical plans a...